Blood samples (3 ml each) were collected from two SARS-CoV-2 IgM positive patients (UPN 1 and UPN 8) affected by advanced breast cancer (stage IV and IIIB, respectively) at three different time points (Baseline, at 2 months, at 7 months). Here, CD40LG is linked to breast cancer.